ArticleBMC cancer2019
Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells.
Xiaofu Qiu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it
ArticleBMC cancer2019
Xiaofu Qiu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.